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Summary The spontaneous reaction of 110 ILM chlorambucil (4-[p-[bis(2-chloroethyl)amino]phenyl]-
butanoic acid; CHB) with 5 mm GSH at 37C in physiological phosphate-buffered saline for 35min gave
primarily the monoglutathionyl derivative, 4-[p-[N-2-chloroethyl,N-2-S-glutathionylethyl]amino]phenyl]-
butanoic acid; CHBSG) and the diglutathionyl derivative, 4-[p-[bis(2-S-glutathionylethyl]amino]phenyl]-
butanoic acid (CHBSG2) with small amounts of the hydroxy-derivatives: 4-[p-[N-2-chloroethyl,N-2-hydroxy-
ethyl]amino] phenyl-butanoic acid (CHBOH) and 4-[p-[N-2-S-glutathionylethyl-2-hydroxyethyl]amino]phenyl]-
butanoic acid (CHBSGOH). The inclusion of approximately physiological amounts of human glutathione
S-transferases (GSTs) Al-i, A2-2, P1-i, Mla-la M3-3 or P1-1 (for nomenclature see Mannervik et al., 1992,
Biochem. J., 282, 305) had little or no catalytic effect on these reactions as determined by loss of CHB.
However, GTSs Al-I and A2-2 were associated with a significant increase of CHBSG at the expense of
CHBSG2 + CHBSGOH suggesting that these GTSs sequestered CHBSG at the active site. This interpretation
was supported by inhibition studies which showed that CHBSG was a pure competitive inhibitor of the
activity of GSTs Al-l and A2-2 towards 1-chloro-2,4-dinitrobenzene with Ki's of 1.3 and 1.2 tiM respectively.
GSH transferases P1-1 and Mla-la were inhibited by CHBSG above 10 LM.
Incubation of 2 tLM CHB, a concentration which may be of more significance for chemotherapy, in the
presence or absence of GST A1-2 (20-50 LM) showed catalysis of GSH monoconjugation equivalent to 18%
of the spontaneous rate. However, the dominant effect again was the sequestration of CHBSG which reached
74.3 ± 1.5 (SEM)% of the total reactants at 60min compared to 28.9 ± 0.3(SEM)% in controls. CHBSG,
although possessing a potential electrophilic centre, showed no detectable alkylation of plasmid DNA but
indirect evidence was obtained that it alkylated other cellular macromolecules.
It is concluded that the contribution of GSTs to catalysis of CHB detoxication will depend on factors not
previously considered, namely the relative molarities of CHB, CHBSG and GSTs, and the cellular capacity to
excrete CHBSG to relieve product inhibition.
Chlorambucil (4-[p-[bis(2-chloroethyl)amino]phenyl]-butanoic
acid; CHB) is a cytototoxic drug used for the treatment of
Hodgkin's and non-Hodgkin's lymphoma, chronic lympho-
cytic leukaemia and ovarian cancer. It is a bifunctional
alkylating agent capable of causing inter-strand covalent link-
age through nucleophilic sites in DNA, principally the N-7
of guanine. It reacts with other cellular nucleophiles includ-
ing glutathione (GSH) to form a monoglutathionyl deriv-
ative, 4-[p-[N-2-chloroethyl, N-2-S-glutathionylethyl]amino]
phenyl]-butanoic acid (CHBSG), a completely detoxified dig-
lutathionyl derivative, 4-[p-[bis(2-S-glutathionylethyl)amino]
phenyl]-butanoic acid (CHBSG2) and with water to yield:
4 -[p -[N-2 -chloroethyl,N-2 -hydroxylethyl]amino]phenylbut-
anoic acid (CHBOH), 4-[p-[bis(2-hydroxyethyl)amino]phenyl]
butanoic acid (CHBOH2) and 4-[p-[N-2-S- glutathionylethyl,
N-2-hydroxyethyl]amino] phenylibutanoic acid (CHBSGOH).
CHB is a hydrophobic anion at physiological pH and was
shown by Bank et al. (1989) to enter and leave leukaemic
lymphocytes rapidly by simple diffusion. In plasma, CHB is
stabilised by binding to albumin (Ehrsson et al., 1981).
A major problem in the use of cancer chemotherapeutics is
the development of cellular resistance and, in the case of
alkylating agents such as CHB, numerous studies suggest
that enhanced expression of glutathione transferases (GSTs)
may contribute to such resistance. For instance: Lewis et al.
(1988) found that amplification of an alpha class GST in a
Chinese hamster ovary (CHO) cell line was associated with
resistance to CHB and other nitrogen mustards; Puchalski
and Fahl (1990) found increased resistance to CHB upon
transfection of mouse and monkey cells with rat GSTs 1-1
(class alpha), 3-3 (class mu) or human GST P1-1 (class pi, for
nomenclature of human GSTs see Mannervik et al., 1992),
and Johnston et al. (1990) found an inverse correlation
between both GSH and total GST activity and CHB-depen-
dent DNA adducts formed in vitro in human chronic lym-
phocytic leukaemic lymphocytes. In support of these
observations, murine GSTs of alpha, mu and pi classes were
shown by Ciaccio et al. (1990) to increase significantly the
rate of formation of CHBSG in vitro at pH 6.5, and the
alpha class enzyme also stimulated the second GSH conjuga-
tion. Recently, Ciaccio et al. (1991) have also observed
catalysis of the GSH conjugaton of CHB by human GSTs of
the alpha and pi classes. In contrast, the transfection of GST
P1-I into NIH 3T3 cells failed to alter their sensitivity to
CHB (Nakagawa et al., 1990). Moreover, Leyland-Jones et
al. (1991) failed to detect a decrease in CHB sensitivity in a
human breast tumour cell line stably transfected with a
human alpha class GSH transferase.
In order to resolve these apparent discrepancies, we have
tested the ability of purified human GSTs to catalyse the
detoxication of CHB in vitro under conditions more com-
parable to those in vivo. The results confirm a catalytic effect
of alpha class GSTs but reveal that GSTs sequester the
partially detoxified primary product, CHBSG which results
in inhibition of catalysis in vitro.
Materials and methods
Preparation ofGSTs
GSH transferase P1-I was prepared from human kidney
cytosol by GSH-agarose affinity chromatography according
to Vander-Jagt et al. (1985), the GSH transferase fraction
being eluted with 20 mM GSH, 2 mM dithiothreitol, 0.1 M
Tris-NaOH, pH 9.6, followed by anion-exchange fplc on a
Mono Q (HR 5/5) column equilibrated in 20 mM Tris-HCI,
pH 7.8 containing 5 mM 2-mercaptoethanol and 10% (v/v)
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glycerol and elution by a linear gradient of NaCI in this
buffer. GSTs Mla-la, Al-i, Al-2 and A2-2 were prepared
from human liver cytosol (HL 133) Tennessee Donor Ser-
vices, Nashville, TN, USA). The GST pool was prepared by
affinity chromatography as above and the alpha enzymes
were then separated from GST Mla-la by hydroxy-apatite
fplc. (HPHT column, Bio-Rad, Richmond, CA, USA) ac-
cording to Hussey et al. (1986). GST Mla-la was finally
purified by anion-exchange fplc at pH 7.8 as described above
for GST P1-1, while the alpha enzymes were similarly
separated at pH 9.5 in 30 mM piperazine-HCI, 5 mM 2-
mercaptoethanol, and 10% (v/v) glycerol as described by
Cmarik et al. (1990). Elution was with a linear gradient of
NaCl in each case.
GST M3-3 was purified from human testis by the same
method used for GST Mla-la above. Specific activities at
37°C towards 1-chloro-2,4-dinitrobenzene (CDNB) (Habig et
al., 1974) were 155, 140, 132, 125, 270 and 35 iLmol min-' mg
protein-' for GSTs P1-i, Al-i, Al-2, A2-2, Mla-la and
M3-3 respectively.
The rat theta class enzyme, GST 5-5, was prepared from
liver cytosol according to Meyer et al. (199la). All GSTs
were >97% pure as judged by reverse phase hplc (Meyer et
al., 1989) and were stored at - 20°C until use.
Analysis ofreaction ofCHB with GSH
CHB reaction was analysed by a method based on that of
Ciaccio et al. (1990). Samples were applied to 250 x 4.6 mm
Dynamax C18 column (Rainin Instruments, Woburn, MS,
USA). Eluent A was 0.1 M ammonium acetate (hplc grade) in
5% (v/v) methanol and eluent B was 0.1 M ammonium
acetate in 90% (v/v) methanol. The column was operated at
1 ml min-' and equilibrated in eluent A. After injection of
sample, products were eluted with a linear gradient from 0 to
100% B over 40 min. The eluent was monitored at 254 nm.
The hydroxy- phosphoryl- and glutathionyl-derivatives were
prepared by incubating chlorambucil for 1 h with water
alone, 0.1 M sodium phosphate, pH 7.0, or phosphate buffer
containing 5 mM GSH respectively. Each sample was separat-
ed by hplc as above. The identities of reaction products were
confirmed by comparison with the analyses of Ciaccio et al.
(1990).
Incubations ofCHB with GSTs
Incubations were carried out with concentrations of GSH,
salts and GSTs which approximate those of cytosol. Thus the
GST to be tested was thawed and both concentrated and
desalted using a Centricon 10 (Amicon, Danvers, MA, USA)
at 0-4°C into 140 mM KCI, 5 mM GSH, 10 mM Na phos-
phate, pH 7.0 (buffer A). In each case a control (minus
enzyme) sample, consisting of an equal volume of the same
buffer of final purification as the GSH transferase, was con-
centrated and desalted in parallel with the enzyme sample.
Buffer A was kept under argon to maintain GSH in the
reduced form. The concentration of GST was determined
from its activity with an appropriate model substrate
immediately prior to incubation with chlorambucil. Chloram-
bucil in dry dimethylformamide (1 mgml-') was added
(3.5% v/v, final concentration 110 EM) to the test sample
containing GST in a capped polypropylene vial at 0-4°C.
Final assay volumes were from 60 to 120 l. A measured
aliquot was immediately removed and added to an equal
volume of 10% (v/v) perchloric acid to give a zero time
sample and the remainder was incubated at 37°C for 5 or
35 min and the reaction terminated with acid as above. Sam-
ples were clarified by microcentrifugation and the unreacted
CHB and its reaction products were separated by reverse
phase hplc (see above) and quantitated from the A254 by
integration (Reeve Analytical, 34 Chapel St, Glasgow, Scot-
land). Since the chromophore of CHB is unaltered during
these reactions, the molar proportions of CHB and its prod-
ucts were determined directly from the integrated absor-
bances at 254 nm. The bulk of the products were the mono-
and di-glutathionyl-conjugates (CHBSG and CHBSG2)
together with a small amount of mono-hydroxy, monog-
lutathionyl conjugate (CHBSGOH). In contrast to the assays
of Ciaccio et al. (1990) carried out in 100mM phosphate
buffer, the phosphate derivatives were negligible (see Figure
1). The zero time sample was analysed and used as a check
that 100% of CHB and metabolites were recovered from
incubated samples. The amounts of CHB, CHBSG, CHBSG2
and CHBSGOH were then expressed as the mole per cent of
their total.
In subsequent experiments the chlorambucil concentration
was reduced to within the range expected intracellularly in
vivo. Thus 1 ml assays contained 2JLM chlorambucil (added
from a stock of 0.1 mgml' of dry dimethylformamide) in
buffer A with or without the heterodimeric human GST
A1-2. Aliquots were removed at 0, 35 and 60 min and
analysed as described above.
To test whether S-hexyl glutathione would inhibit the
effects of GST A1-2 on CHB reaction, 0.4 ml assys were
carried out for 60 min with 4tLM CHB and either 12i4M or
100ylM S-hexyl glutathione and analysed as described above.
To test whether the effect of GST A1-2 on CHB reaction
might be modified by the presence of cellular macromole-
cules, the following fraction was prepared: 2 ml human
kidney cytosol, from which the GSTs had been removed by
passage through GSH-agarose, was dialysed for 48 h at
0-4°C (three changes) against 0.1 M KCI, 2 mM dithio-
threitol, 10% glycerol, 10 mM Na phosphate, pH 7.0 to
remove acid-soluble compounds which would interfere with
the hplc analysis and then passed through a 1 ml column of
Affi-gel blue equilibrated in this buffer to remove serum
albumin (which stabilises CHB). For assay with CHB, a
0.3 ml aliquot of this crude macromolecule fraction was
transferred into buffer A using a desalting Sephadex column
(PD-10, Pharmacia-LKB, Uppsala, Sweden). The sample
volume was 1.4 ml. A second aliquot was mixed with 0.3 ml
purified GST A1-2 and similarly treated. Protein concentra-
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Figure 1 Separation of chlorambucil and its glutathione con-
jugates by reverse phase hplc. One ml of buffer A containing
2001M chlorambucil and 10% (v/v) dimethyl formamide was
incubated at 37°C for 35 min and analysed by reverse phase hplc
as described in the text. The products were identified from
separate incubations of chlorambucil in water or in dilute
phosphate-buffered saline which yield the hydroxy- and
phosphoryl-products, but no GSH conjugates (Ciaccio et al.,
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tion was determined by the method of Bradford (1976).
These samples and controls containing only buffer A were
then incubated with CHB and analysed as described above.
Inhibition studies
CHB, CHBSG and CHBSG2 were collected from reverse
phase hplc runs of a 1 ml incubation of 200gM CHB in
buffer A containing 10% (v/v) dimethylformamide. Control
samples were also collected from appropriate positions on the
gradient of a blank hplc run. GST activity with CDNB was
determined in 250AlI of 1 mM GSH, 100 mM NaCl, 1OmM
Na phosphate, pH 6.5 at 24°C using an MCC 340 Mk II
microtiter plate reader (ICN-Flow, High Wycombe, Bucks,
UK). Assays, in duplicate or triplicate, contained buffer,
GSH transferase and 3% of appropriate hplc gradient solu-
tion with or without inhibitor. Reactions were initiated by
addition of CDNB and the reaction monitored for 10 s at
340 nm. Enzyme inhibition was analysed using the Kinenort
program kindly provided by Dr A.G. Clark.
100% of the added CHB showing a lack of covalent reaction
with GSTs. Catalysis by GST Al-I was equivalent to only
5-10% of the non-catalytic rate at this pH. Surprisingly the
increased level of CHBSG in the presence of GST Al-I was
greater than expected from the loss of CHB, being associated
with a decrease in formation of CHBSG2 and CHBSGOH.
The increase of CHBSG in the presence of GST Al-I sug-
gested that it was protecting this intermediate from further
reaction through the well characterised capacity of GSTs as
non-covalent binding proteins (Ketterer et al., 1978; Listow-
sky et al., 1988). Similar effects on CHBSG accumulation are
seen with GSTs A2-2, P1-I and Mla-la, but not GST M3-3.
The rat theta class enzyme, GST 5-5, used in lieu of its
human equivalent, was also tested because it generally shows
high activity towards a number of alkyl halides (Meyer et al.,
1991a) but no catalysis of CHB-GSH conjugation was
observed.
The apparent sequestration of CHBSG by GSTs Al-i,
A2-2, Mla-la and P1-1 was investigated further by testing
CHBSG and CHBSG2 as inhibitors of GST activity.
Alkylation ofguanine-N7 in plasmid DNA
Chlorambucil, CHBSG and CHBOH were collected from an
hplc separation as for the inhibition studies above. The
methanol was removed by rotary evaporation under reduced
pressure and the samples freeze-dried to remove ammonium
acetate. After dissolving the compounds to approximately
10 JAM in dry dimethylformamide, their purity and concentra-
tion were determined by hplc analysis of an aliquot. The
ability of CHB, CHBSG and CHBOH (0.1 and 0.33 mM) to
alkylate guanine-N7 in the plasmid pBR322 was determined
in 25 mM triethanolamine-HCI, pH 7.2 by the method of
Hartley et al. (1986).
Inhibition ofGSTs
The activity of GSTs Al-l and A2-2 towards CDNB was
inhibited by CHBSG. These assays last for less than 10 s so
the instability of CHBSG is not significant. Dixon plots (e.g.
Figure 3a) and Hanes plots (e.g. Figure 3b) indicated pure,
competitive inhibition with respect to CDNB in each case
with Ki's of 1.3 ± 0.2(SEM) JAM for GST Al-l and 1.2 ± 0.3
(SEM) JAM for GST Al-2. CHBSG2 was a less potent inhibi-
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Results
Testingfor catalysis ofCHB-GSH conjugation by GSTs
CHB (110 JAM) was incubated for 35 min at 37°C in a
medium at pH 7.0 containing intracellular levels of salts,
phosphate and GSH in the presence and absence of physio-
logical concentrations of specific GSTs (Figure 2). In the
absence of enzyme 61.7% of CHB had reacted with GSH
and water yielding 39.8% CHBSG, 19.2% CHBSG2 and
2.7% CHBSGOH after 35 min. In the presence of individual
GSTs, only GST Al-I (52 JM) showed significant catalysis as
measured by the decrease in CHB remaining. Recovery of
CHB, CHBSG, CHBSG2 and CHBSGOH was approximately
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Figure 2 Effect of Human GSTs on reaction of 100 JAM CHB.
GSTs were prepared and incubated with 110gM CHB in physio-
logical saline pH, 7.0 containing 5 mM GSH for 1 h at 37°C and
the reaction products analysed by hplc all as described in the
'Methods'. Unshaded bars, no GST added; shaded bars, 52 JAM
GST Al-i; diagonal bars, 24 JAM GST A2-2, horizontal bars,
30 luM GST P1-1, and hatched bars, 25lJM GST MIa-la. Individ-
ual GST-containing assays are compared with four controls,
error bars indicating SD. Significant differences from the normal
SD of control are indicated by: *P <0.05; **P <0.02;
***P<0.01. Ordinate is more per cent of total components.
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Figure 3 Inhibition of GSH transferase A2-2 by CHBSG. The
activity of GSH transferase A2-2 towards CDNB in the presence
or absence of CHBSG was measured and analysed as described
in the text. a, Dixon plot obtained in the presence of I mM GSH,
1 mM CDNB and several concentrations of CHBSG; b, Hanes
plot of data obtained with 1 mM GSH, 1 mM CDNB in the
presence (U) or absence (A) of 1.6 JAM CHBSG.436 D.J. MEYER et al.
tor yielding a Ki of 5.2 ± l.l(SEM ylM for GST Al-i, while
CHB did not inhibit significantly in this range.
GSTs P1-1 and Mla-la were only significantly inhibited by
CHBSG at concentrations greater than 1OjiM.
Effect ofGSTAl-2 on CHB reaction at concentrations of
clinical relevance
The above experiments suggested that the low level of
catalysis seen with 11I0 tM CHB was due to product inhibi-
tion. The question then arose of the catalytic effect of GSTs
at the lower concentrations of CHB which may be attained
with a chemotherapeutic dose (< 5gM). Such assays, with an
initial concentrationm of CHB of 2 JM, were carried out in a
larger volume for accurate analysis and required larger
amounts of GST. GST Al-2, the alpha class isoenzyme most
readily available was chosen for study. The results (Figure 4)
clearly show a decrease in remaining CHB in the presence of
52gM GST Al-2, more evident at 35 than at 60 min, due to
catalysis of GSH conjugation. More marked is the stabilisa-
tion of CHBSG which reached 74.3 ± 1.5(SEM)% of the
total products at 60 min compared to 28.9 ± 0.3(SEM)% in
the control. In assays stopped at 5 min 10.8% of CHB was
conjugated with GSH in control compared with 14.9% in the
presence of GST Al-2 (data not shown).
If the stabilisation of CHBSG by GST Al-2 is due to
sequestration at the enzyme active site, the effect should be
prevented by other inhibitors of activity. In Figure 5 is
shown the results of inclusion of S-hexyl glutathione, an
inhibitor of the l-chloro-2,4-dinitrobenzene GSH transferase
activity with Ki 3 JAM (Mannervik & Danielson, 1988) on the
reaction of 4 JAM CHB in the presence of 36 JAM GST Al-2.
While 1OJM S-hexyl glutathione had no significant effect on
CHB conjugation or CHBSG stabilisation by the GST,
100jaM of the inhibitor completely prevented the effects of
the GST. Thus, in a physiological situation the relatively high
molarity of the GST is an important factor, low levels of
inhibitor being insufficient to titrate the enzyme present with
significant effect.
To test whether GST Al-2 could sequester CHBSG in the
presence of other cellular constituents a crude soluble macro-
molecule fraction including proteins and nucleic acids was
prepared from human kidney. Serum albumin was removed
since it stabilises CHB (Ehrsson et al., 1981). In Table I is
shown the amounts of CHB and reaction products obtained
in the presence and absence of the macromolecule fraction,
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Figure 5 Effect of S-hexyl glutathione on the capacity of GST
A1-2 to alter the reaction of CHB with GSH CHB (2gM) was
incubated at 37'C in physiological saline pH 7.0 containing 5 mM
GSH for 60 min alone (open bars), with 36gm GST A1-2
(shaded bars), with GST Al-2 + 1OjiM S-hexyl glutathione (diag-
nonal bars) or with GST Al-2 + 100LM S-hexyl glutathione
(horizontal bars). Error bars indicate SD. Significant differences
(Student t-test) are given by: *P <0.05; **P <0.002;
***P <0.001.
and the effect of inclusion of 30JAM GST Al-2. In the
presence of the macromolecule fraction (12 mg pro-
tein' ml-') but without GST A1-2, only 58.8% of the drug
was recovered as CHB, CHBSG, CHBSG2 and CHBSGOH.
Losses are presumably due to alkylation of macromolecules.
A comparison between the yield of CHBSG and (CHBSG2
plus CHBSGOH) in the presence and absence of the macro-
molecule fraction indicates that components of the macro-
molecule fraction are alkylated not only by CHB but also by
CHBSG. In the presence of GST Al-2 the recovery of CHB
and its GSH reaction products is increased to 80.9% and
significant catalysis of GSH conjugation and stabilisation of
CHBSG are observed.
Alkylation ofguanine-N7
In order to assess the toxicological significance of the seques-
tration of CHBSG, its ability to alkylate DNA was com-
pared with that of CHB and CHBOH. The autoradiographs
showed that, while CHBOH alkylated the plasmid as
efficiently as CHB at 0.1 and 0.33 mM, CHBSG gave no
detectable DNA alkylation under these conditions (data not
shown).
35 60 35 60
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Figure 4 Effect of GST A1-2 on reaction of 2 jLM CHB CHB
(2gM) was incubated at 37°C in the presence or absence of 36JAM
GST Al-2 in physiological saline, pH 7.0 containing 5 mm GSH
for 35 min (single assays) or 60 min (five assays) and products
analysed by hplc all as described in the 'Methods'. Unshaded
bars, no GST added; shaded bars, plus GST Al-2. Error bars
indicate SD. Significant differences (Student t-test) are given by:
*P<0.02 and **P<0.001.
Discussion
The results confirm the findings of Ciaccio et al. (1991) that
human alpha class GSTs catalyse the first GSH conjugation
of CHB. However, it is also shown that an important effect,
particularly at low concentrations of CHB, is the non-
covalent sequestration of the primary product CHBSG. This
also occurs with GSTs P1-1 and Mla-la but the alpha class
GSTs are most sensitive to CHBSG as judged by inhibition
of activity. This interpretation is confirmed by the ability of
S-hexyl glutathione to inhibit both catalysis of CHB conjuga-
tion and CHBSG sequestration of GST Al-2. Both effects
were also seen in the presence of a mixture of potentially
competing macromolecules, so they may well occur in
cytosol. No evidence ofcatalysis of the second GSH conjuga-
tion was obtained. The human alpha class GSTs therefore
differ markedly from the murine alpha GST studied by Ciaccio
et al. (1990) which catalyses the GSH conjugation of both
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Table I Effect of GST A1-2 on CHB reaction in the presence of a crude cellular
macromolecule fraction
Recovery CHB CHBSG CHBSG2 CHBSGOH
Sample % % % % %
Buffer A control 100 17.9 + 2.4 28.3 + 1.7 43.0 ± 2.7 10.5 ± 0.8
Fraction M 58.8 ± l.la 17.0 0.8 17.9 0.la 18.8 0.2a 5.1 ±.Oa
Fraction M + GST 80.9 ± 2.1b 14.8 ± 1.3b 49.4 ± 2.5b 12.9 0.6b 4.0 ± 0.8
A crude human kidney macromolecule fraction (M) lacking albumin and GSTs was
prepared and incubated with 4gM CHB in buffer A in the presence or absence of 30IM GST
A1-2. CHB and GSH reaction products were analysed as described in the Methods. Values are
means of three determinations ± SD. aSignificantly different from control, P <0.001.
bSignificantly different from fraction M (no GST), P >0.001.
CHB and CHBSG. Recently the primary sequence of the
murine alpha GST subunit (mYc) was obtained by Beutler
and Eaton (1992) and it is clearly more closely related to the
rat liver GST subunit 10 (Meyer et al., 1991b) and/or Yc2
(Hayes et al., 1991) rather than the major rat alpha GST
subunits la, lb and 2. GST subunit 10 occurs mainly in
foetal and neonatal rat liver (Tee et al., 1992) and may also
be induced in adult liver by 1,2-dithiole-3-thione (Meyer et
al., 1992) or ethoxyquin (Hayes et al., 1991). It is possible
that the alpha class GST associated with CHB-resistance in
hamster cells (Lewis et al., 1988) is also more closely related
to this type of alpha class subunit. To date, a human equiva-
lent of mYc (or rat subunit 10/Yc2) has not been discovered.
In their study of human GSTs, Ciaccio et al. (1991)
obtained kinetic data on the catalysis of the first GSH con-
jugation of CHB. They obtained Km values for CHB of 19,
150, 220 and 8301tM for GSTs Al-i, Al-2, A2-2 and P1-I
respectively. These assays were carried out at lower, non-
physiological, pH (6.5) which reduces the relative contribu-
tion of the non-catalytic reaction rate and were terminated at
2.5 min before the inhibitory effects of CHBSG were appar-
ent. The results presented here show that at physiological
pH; with concentrations of salts, GSH and GSTs approxi-
mating those in cells, and amounts of CHB and time periods
similar to those pertaining to chemotherapy, the catalysis of
CHB conjugation with GSH is of marginal significance com-
pared to the non-catalytic reaction. However, the sequestra-
tion of CHBSG is an important effect.
The significance of CHBSG sequestration cannot be read-
ily assessed without further knowledge if its toxicity. When
CHB was incubated with a crude soluble macromolecule
fraction lacking GSTs and albumin, reduced recoveries of
CHBSG, CHBSG2 and CHBSGOH were attributable to the
alkylation of macromolecules by both CHB and the mono-
functional CHBSG. When GST A1-2 was added, both its
catalytic and sequestration effects were observed and the
apparent alkylation of macromolecules was considerably
reduced. The apparent alkylation due to CHBSG is likely to
be ofproteins rather than nucleic acids since no alkylation of
guanine in DNA was observed with this compound.
Since GS-conjugates do not enter cells by diffusion, it is
not possible to examine the toxicity of CHBSG formed inside
the cell from CHB simply by adding CHBSG to cells. It has
long been known that the monofunctional form of CHB
(4-[p-N-2-chloroethylaminobenzene]-butanoic acid) is as toxic
to normal cells as CHB (Connors et al., 1960), but to what
extent protein alkylation contributes to toxicity is unknown.
Despite these uncertainties, it may be surmised that the
function of GSTs A1/2 in cells treated with CHB will tend to
be inhibited by CHBSG. The extent of inhibition will depend
on the concentrations of both the GSTs and CHBSG. The
concentration of CHBSG will in turn depend on the capacity
of the cell to export the conjugate via a plasma membrane
ATP-dependent system (Ishikawa et al., 1990; Elferink et al.,
1991; Singhal et al., 1991; Akerboom et al., 1992). If CHBSG
can be rapidly excreted without inactivating the transport
system through alkylation, the presence of human alpha class
GSTs at a concentration of 5-10I1M, as found for instance
in ovarian carcinoma samples (Green et al., 1990), would be
expected to contribute significantly to CHB detoxication
through direct catalysis of CHBSG formation. Protein
alkylation by CHBSG should also be much reduced. If,
however, CHBSG excretion is slow, CHBSG will rapidly
accumulate and inhibit not only the catalytic detoxication of
CHB but perhaps also other protective functions of alpha
class GSTs such as the inhibition of lipid peroxidation via
their selenium-independent GSH peroxidase activity (Tan et
al., 1984). In this case the GST should contribute little or
nothing to protection against CHB toxicity. Variations in the
relative concentrations of GSTs and CHBSG may thus ex-
plain the disparity between the results of Leyland-Jones et al.
(1991) who found no CHB-protective effect of transfected
human GST Al-I in MCF-7 cells and those of for example
Puchalski and Fahl (1990), who obtained positive results for
rat alpha GST using transfection of mouse (1.2-fold-
resistant) and monkey cells (1.4-fold-resistant).
In order to achieve sensitisation to CHB of resistant cells,
GST inhibitors such as ethacrynic acid have been used (Tew
et al., 1988; Hansson et al., 1991). Moreover, ethacrynic acid
was recently used to inhibit GSTs in a phase I study
(O'Dwyer et al., 1991). The basis for such use was the low Ki
value for human GSTs with ethacrynic acid and its GS-
conjugate in the range of 0.1-6pM (Ploeman et al, 1990).
However, it is clear from the data presented here that a Ki of
about 1 jAM is of little significance when the cellular concen-
tration of GST is for example, 10 JAM as found in ovarian
carcinoma samples (Green et al., 1990). Thus 1OJM S-hexyl
glutathione had no detectable effect on GST Al-2 when the
latter was in molar excess (Figure 5). The sensitisation to
CHB due to ethacrynic acid may result not only from direct
inhibition of activity, but also from competition between the
GS-conjugates of ethacrynic acid and CHB for excretion.
The studies presented in this paper emphasise that to inhibit
GSTs in vivo it is important to consider both the relatively
high molar concentration of these enzymes and cellular
capacity to excrete GSH conjugates.
The authors are grateful to B. Coles for helpful discussions. This
work was supported by the Cancer Research Campaign.
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